▶ 調査レポート

治療計画システム&高度画像処理のグローバル市場(~2027):3D画像再構成、GPU使用型イメージレジストレーション、室内イメージング

• 英文タイトル:Treatment Planning Systems & Advanced Image Processing Market Research Report by Technique, Type of Software, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。治療計画システム&高度画像処理のグローバル市場(~2027):3D画像再構成、GPU使用型イメージレジストレーション、室内イメージング / Treatment Planning Systems & Advanced Image Processing Market Research Report by Technique, Type of Software, Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2304F084資料のイメージです。• レポートコード:MRC2304F084
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、242ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥692,860 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,392,860 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社の本調査レポートによると、2021年に1,741.10百万ドルであった世界の治療計画システム&高度画像処理市場規模は2022年に1,892.05百万ドルになり、更に年平均8.84%拡大して2027年までに2,895.50百万ドルに達する見通しです。本書は、治療計画システム&高度画像処理の世界市場についての多面的な調査を元に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、技術別(3D画像再構成、GPU使用型イメージレジストレーション、室内イメージング)分析、ソフトウェア種類別(自動輪郭作成ソフトウェア、DICOM - RTソフトウェア、マルチモダリティソフトウェア、PET/CT変形可能ソフトウェア)分析、用途別(適応放射線治療、線量蓄積、オンラインモニタリング、追跡、イメージレジストレーション検証)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの内容をまとめた市場調査レポートです。なお、本書に掲載されている企業情報には、Accuray Incorporated、AIM Specialty Health、BEBIG SA、Brainla、Brainlab AG、Braun Melsungen AG、CANON MEDICAL SYSTEMS CORPORATION、DOSIsoft SA、Eckert & Ziegler AG、Elekta、Elekta AB、Fuji Electric Co., Ltd.などが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界の治療計画システム&高度画像処理市場規模:技術別
- 3D画像再構成の市場規模
- GPU使用型イメージレジストレーションの市場規模
- 室内イメージングの市場規模
・世界の治療計画システム&高度画像処理市場規模:ソフトウェア種類別
- 自動輪郭作成ソフトウェアの市場規模
- DICOM - RTソフトウェアの市場規模
- マルチモダリティソフトウェアの市場規模
- PET/CT変形可能ソフトウェアの市場規模
・世界の治療計画システム&高度画像処理市場規模:用途別
- 適応放射線治療における市場規模
- 線量蓄積における市場規模
- オンラインモニタリングにおける市場規模
- 追跡における市場規模
- イメージレジストレーション検証における市場規模
・世界の治療計画システム&高度画像処理市場規模:地域別
- 南北アメリカの治療計画システム&高度画像処理市場規模
アメリカの治療計画システム&高度画像処理市場規模
カナダの治療計画システム&高度画像処理市場規模
ブラジルの治療計画システム&高度画像処理市場規模
...
- アジア太平洋の治療計画システム&高度画像処理市場規模
日本の治療計画システム&高度画像処理市場規模
中国の治療計画システム&高度画像処理市場規模
インドの治療計画システム&高度画像処理市場規模
韓国の治療計画システム&高度画像処理市場規模
台湾の治療計画システム&高度画像処理市場規模
...
- ヨーロッパ/中東/アフリカの治療計画システム&高度画像処理市場規模
イギリスの治療計画システム&高度画像処理市場規模
ドイツの治療計画システム&高度画像処理市場規模
フランスの治療計画システム&高度画像処理市場規模
ロシアの治療計画システム&高度画像処理市場規模
...
- その他地域の治療計画システム&高度画像処理市場規模
・競争状況
・企業情報

The Global Treatment Planning Systems & Advanced Image Processing Market size was estimated at USD 1,741.10 million in 2021 and expected to reach USD 1,892.05 million in 2022, and is projected to grow at a CAGR 8.84% to reach USD 2,895.50 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Treatment Planning Systems & Advanced Image Processing to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technique, the market was studied across 3D Image Reconstruction, Image Registration using Graphics Processor Unit, and In-Room Imaging.

Based on Type of Software, the market was studied across Auto-Contouring Software, DICOM-RT Software, Multi-Modality Software,, and PET/CT Deformable Software.

Based on Application, the market was studied across Adaptive Radiotherapy, Dose Accumulation, Online Monitoring, Tracking, and Validation of Image Registration.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Treatment Planning Systems & Advanced Image Processing market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Treatment Planning Systems & Advanced Image Processing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Treatment Planning Systems & Advanced Image Processing Market, including Accuray Incorporated, AIM Specialty Health, BEBIG SA, Brainla, Brainlab AG, Braun Melsungen AG, CANON MEDICAL SYSTEMS CORPORATION, DOSIsoft SA, Eckert & Ziegler AG, Elekta, Elekta AB, Fuji Electric Co., Ltd., IBA (Ion Beam Applications S.A.), IQ-AI Ltd., Koninklijke Philips N.V., Koninklijke Philips NV, Merit Medical Systems, MIM Software Inc., Panacea Medical Technologies Pvt. Ltd, RaySearch Laboratories AB, REMEDI Co., Ltd., Salutaris Medical Devices, Schlumberger Limited, Siemens Healthineers AG, Varian Medical Systems, Inc., and ViewRay, Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Treatment Planning Systems & Advanced Image Processing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Treatment Planning Systems & Advanced Image Processing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Treatment Planning Systems & Advanced Image Processing Market?
4. What is the competitive strategic window for opportunities in the Global Treatment Planning Systems & Advanced Image Processing Market?
5. What are the technology trends and regulatory frameworks in the Global Treatment Planning Systems & Advanced Image Processing Market?
6. What is the market share of the leading vendors in the Global Treatment Planning Systems & Advanced Image Processing Market?
7. What modes and strategic moves are considered suitable for entering the Global Treatment Planning Systems & Advanced Image Processing Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of cancer and growing demand for accurate oncology treatment practices
5.1.1.2. Evolving healthcare IT sector with supportive infrastructure
5.1.1.3. Rising investments in oncology treatment and care segments
5.1.2. Restraints
5.1.2.1. Inadequacy of healthcare personnel
5.1.3. Opportunities
5.1.3.1. Increasing adoption of Artificial Intelligence (AI) and Machine Learning (ML) into oncology processes
5.1.3.2. Accelerating government initiatives and support towards public-private partnerships in the oncology and radiotherapy space
5.1.3.3. Wide-scale adoption in treatment planning, treatment simulation, and image guidance in radiotherapy processes
5.1.4. Challenges
5.1.4.1. Cybersecurity and privacy concerns
5.2. Cumulative Impact of COVID-19

6. Treatment Planning Systems & Advanced Image Processing Market, by Technique
6.1. Introduction
6.2. 3D Image Reconstruction
6.3. Image Registration using Graphics Processor Unit
6.4. In-Room Imaging

7. Treatment Planning Systems & Advanced Image Processing Market, by Type of Software
7.1. Introduction
7.2. Auto-Contouring Software
7.3. DICOM-RT Software
7.4. Multi-Modality Software,
7.5. PET/CT Deformable Software

8. Treatment Planning Systems & Advanced Image Processing Market, by Application
8.1. Introduction
8.2. Adaptive Radiotherapy
8.3. Dose Accumulation
8.4. Online Monitoring
8.5. Tracking
8.6. Validation of Image Registration

9. Americas Treatment Planning Systems & Advanced Image Processing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Treatment Planning Systems & Advanced Image Processing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Treatment Planning Systems & Advanced Image Processing Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Accuray Incorporated
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. AIM Specialty Health
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. BEBIG SA
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Brainla
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Brainlab AG
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Braun Melsungen AG
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. CANON MEDICAL SYSTEMS CORPORATION
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. DOSIsoft SA
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Eckert & Ziegler AG
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Elekta
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Elekta AB
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Fuji Electric Co., Ltd.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. IBA (Ion Beam Applications S.A.)
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. IQ-AI Ltd.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Koninklijke Philips N.V.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Koninklijke Philips NV
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Merit Medical Systems
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. MIM Software Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Panacea Medical Technologies Pvt. Ltd
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. RaySearch Laboratories AB
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. REMEDI Co., Ltd.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Salutaris Medical Devices
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Schlumberger Limited
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Siemens Healthineers AG
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Varian Medical Systems, Inc.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
13.26. ViewRay, Inc.
13.26.1. Business Overview
13.26.2. Key Executives
13.26.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing